Literature DB >> 18026693

The A946T polymorphism in the interferon induced helicase gene does not confer susceptibility to Graves' disease in Chinese population.

Ze-Fei Zhao1, Bin Cui, Hao-Yan Chen, Shu Wang, Imelda Li, Xue-Jiang Gu, Li Qi, Xiao-Ying Li, Guang Ning, Yong-Ju Zhao.   

Abstract

Genetic susceptibility plays a major role in the etiology of Graves' disease (GD). A recent study revealed that the A946T polymorphism (rs1990760) in interferon induced helicase (IFIH1) gene was a susceptible locus for GD. A case-control study in a Chinese population was undertaken, with 261 GD patients and 206 healthy subjects, to analyze the association of A946T polymorphism in IFIH1 gene with GD. In addition, the distribution of IFIH1 genotypes was investigated in subgroups according to the onset age and the Graves' ophthalmopathy (GO). No significant differences in the allele and genotype frequencies for A946T polymorphism were found between GD patients and healthy controls (chi2 = 2.834, P = 0.242; chi2 = 1.127, P = 0.288). The genotype-phenotype correlation was not identified either. Therefore we were unable to find the association of A946T polymorphism of the IFIH1 gene with the development of GD in a Chinese population.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18026693     DOI: 10.1007/s12020-007-9024-z

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  25 in total

1.  Evidence for a major role of heredity in Graves' disease: a population-based study of two Danish twin cohorts.

Authors:  T H Brix; K O Kyvik; K Christensen; L Hegedüs
Journal:  J Clin Endocrinol Metab       Date:  2001-02       Impact factor: 5.958

Review 2.  Graves' disease.

Authors:  A P Weetman
Journal:  N Engl J Med       Date:  2000-10-26       Impact factor: 91.245

3.  Shared and unique functions of the DExD/H-box helicases RIG-I, MDA5, and LGP2 in antiviral innate immunity.

Authors:  Mitsutoshi Yoneyama; Mika Kikuchi; Kanae Matsumoto; Tadaatsu Imaizumi; Makoto Miyagishi; Kazunari Taira; Eileen Foy; Yueh-Ming Loo; Michael Gale; Shizuo Akira; Shin Yonehara; Atsushi Kato; Takashi Fujita
Journal:  J Immunol       Date:  2005-09-01       Impact factor: 5.422

4.  The codon 620 tryptophan allele of the lymphoid tyrosine phosphatase (LYP) gene is a major determinant of Graves' disease.

Authors:  M R Velaga; V Wilson; C E Jennings; C J Owen; S Herington; P T Donaldson; S G Ball; R A James; R Quinton; P Perros; S H S Pearce
Journal:  J Clin Endocrinol Metab       Date:  2004-11       Impact factor: 5.958

5.  Histocompatibility leucocyte antigens and closely linked immunomodulatory genes in autoimmune thyroid disease.

Authors:  P J Hunt; S E Marshall; A P Weetman; M Bunce; J I Bell; J A Wass; K I Welsh
Journal:  Clin Endocrinol (Oxf)       Date:  2001-10       Impact factor: 3.478

6.  CTLA-4 gene polymorphism at position 49 in exon 1 reduces the inhibitory function of CTLA-4 and contributes to the pathogenesis of Graves' disease.

Authors:  T Kouki; Y Sawai; C A Gardine; M E Fisfalen; M L Alegre; L J DeGroot
Journal:  J Immunol       Date:  2000-12-01       Impact factor: 5.422

7.  Multiple SNPs in intron 7 of thyrotropin receptor are associated with Graves' disease.

Authors:  Hitomi Hiratani; Donald W Bowden; Satoshi Ikegami; Senji Shirasawa; Akira Shimizu; Yoshinori Iwatani; Takashi Akamizu
Journal:  J Clin Endocrinol Metab       Date:  2005-03-01       Impact factor: 5.958

8.  Human T cell leukemia virus type I-infected patients with Hashimoto's thyroiditis and Graves' disease.

Authors:  Takehiro Matsuda; Mariko Tomita; Jun-Nosuke Uchihara; Taeko Okudaira; Kazuiku Ohshiro; Takeaki Tomoyose; Tomoki Ikema; Masato Masuda; Mineki Saito; Mitsuhiro Osame; Nobuyuki Takasu; Takao Ohta; Naoki Mori
Journal:  J Clin Endocrinol Metab       Date:  2005-08-02       Impact factor: 5.958

Review 9.  Autoimmune thyroid disease: further developments in our understanding.

Authors:  A P Weetman; A M McGregor
Journal:  Endocr Rev       Date:  1994-12       Impact factor: 19.871

10.  Genomic polymorphism at the interferon-induced helicase (IFIH1) locus contributes to Graves' disease susceptibility.

Authors:  Alison Sutherland; Jocelyn Davies; Catherine J Owen; Suresh Vaikkakara; Christine Walker; Timothy D Cheetham; R Andrew James; Petros Perros; Peter T Donaldson; Heather J Cordell; Richard Quinton; Simon H S Pearce
Journal:  J Clin Endocrinol Metab       Date:  2007-05-29       Impact factor: 5.958

View more
  5 in total

1.  IFIH1 polymorphisms are significantly associated with type 1 diabetes and IFIH1 gene expression in peripheral blood mononuclear cells.

Authors:  Siyang Liu; Hongjie Wang; Yulan Jin; Robert Podolsky; M V Prasad Linga Reddy; Jennifer Pedersen; Bruce Bode; John Reed; Dennis Steed; Steve Anderson; Ping Yang; Andy Muir; Leigh Steed; Diane Hopkins; Yihua Huang; Sharad Purohit; Cong-Yi Wang; Andrea K Steck; Annalisa Montemari; George Eisenbarth; Marian Rewers; Jin-Xiong She
Journal:  Hum Mol Genet       Date:  2008-10-16       Impact factor: 6.150

Review 2.  Selective IgA deficiency in autoimmune diseases.

Authors:  Ning Wang; Nan Shen; Timothy J Vyse; Vidya Anand; Iva Gunnarson; Gunnar Sturfelt; Solbritt Rantapää-Dahlqvist; Kerstin Elvin; Lennart Truedsson; Bengt A Andersson; Charlotte Dahle; Eva Ortqvist; Peter K Gregersen; Timothy W Behrens; Lennart Hammarström
Journal:  Mol Med       Date:  2011-08-04       Impact factor: 6.354

3.  The new perspectives on genetic studies of type 2 diabetes and thyroid diseases.

Authors:  Min Xu; Yufang Bi; Bin Cui; Jie Hong; Weiqing Wang; Guang Ning
Journal:  Curr Genomics       Date:  2013-03       Impact factor: 2.236

4.  The genetic basis of graves' disease.

Authors:  Rafał Płoski; Konrad Szymański; Tomasz Bednarczuk
Journal:  Curr Genomics       Date:  2011-12       Impact factor: 2.236

5.  The rs1990760 polymorphism within the IFIH1 locus is not associated with Graves' disease, Hashimoto's thyroiditis and Addison's disease.

Authors:  Marissa Penna-Martinez; Elizabeth Ramos-Lopez; Inka Robbers; Heinrich Kahles; Stefanie Hahner; Holger Willenberg; Nicole Reisch; Christian Seidl; Maria Segni; Klaus Badenhoop
Journal:  BMC Med Genet       Date:  2009-12-04       Impact factor: 2.103

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.